HENWOOD GERALDINE A.,MACK RANDALL J.,KOLENG JR. JOHN JOSEPH,SHARR CHRISTOPHER T.,FREYER CHARLES ALEXANDER
申请号：
NZ62699912
公开号：
NZ626999A
申请日:
2012.12.11
申请国别(地区):
NZ
年份:
2016
代理人:
摘要：
Provided is the use of dexmedetomidine in the preparation of a pharmaceutical composition for treating or preventing pain without significant sedation in a subject, wherein said pharmaceutical composition is formulated to be administered intranasally as a unit dosage comprising about 10 µg, about 15 µg, about 20 µg, about 25 µg, about 30 µg, about 35 µg, about 40 µg, about 45 µg or about 50 µg dexmedetomidine. Further provided are intranasal formulations comprising dexmedetomidine and metered dose devices comprising such formulations.
